top of page

Ozempic® is a prescription injection pen developed by Novo Nordisk, a pharmaceutical company from Denmark. Its active ingredient is semaglutide, which belongs to the GLP-1 (glucagon-like peptide-1) receptor agonist class of medicines.

Ozempic® may help support overall metabolic health by improving insulin secretion, stabilising blood glucose levels, and assisting with weight control. Ozempic® has been approved by the U.S. FDA and the European Medicines Agency (EMA) since 2017, and is widely used in many regions worldwide, including Hong Kong.

 

Ozempic® | GLP-1 Receptor Agonist | Semaglutide | Weight Loss Pen | 100% Authentic

HK$3,080.00Price
Quantity
  • HK-66485

媒體報道

ULH
img5-ac9e7996.png
d42fe035-f6ea-421e-ad63-050598110347.JPG
經濟日報
img4-9e7420ca.png
yahoo-news.png
bottom of page